HPC Biosciences Ltd. said its normalized net income for the fiscal first half ended Sept. 30 amounted to 2 Indian paise per share, an increase of 49.0% from 1 paise per share in the year-earlier period.
Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was 2.9 million rupees, a gain of 52.3% from 1.9 million rupees in the prior-year period.
Total revenue rose 68.2% on an annual basis to 14.5 million rupees from 8.6 million rupees, and total operating expenses increased 63.7% from the prior-year period to 9.8 million rupees from 6.0 million rupees.
Reported net income rose 50.7% from the prior-year period to 4.5 million rupees, or 3 paise per share, from 3.0 million rupees, or 2 paise per share.
As of Dec. 1, US$1 was equivalent to 61.95 Indian rupees.
